Karolinska Development AB ser. B (KDEV) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.18 Million ≈ $-449.51K USD) by net assets (Skr1.10 Billion ≈ $118.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KDEV net asset quality index to measure how much of total assets are equity-financed.

Karolinska Development AB ser. B - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Karolinska Development AB ser. B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Karolinska Development AB ser. B cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Karolinska Development AB ser. B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Karolinska Development AB ser. B ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Enjoei S.A SA:ENJU3	0.112x
SHH Resources Holdings Bhd KLSE:7412	0.048x
SAN-EL Muhendislik Elektrik Taahhut Sanayi ve Ticaret AS IS:SANEL	-0.255x
Western Alaska Minerals Corp V:WAM	-0.616x
IT Link PA:ALITL	0.065x
CIFI Holdings (Group) Co. Ltd F:6CI	0.064x
Duksung KO:004830	0.014x
Bintai Kinden Corporation Bhd KLSE:6998	0.007x

Annual Cash Flow Conversion Efficiency for Karolinska Development AB ser. B (2008–2025)

The table below shows the annual cash flow conversion efficiency of Karolinska Development AB ser. B from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Karolinska Development AB ser. B worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.04 Billion ≈ $112.44 Million	Skr-26.06 Million ≈ $-2.80 Million	-0.025x	-11.01%
2024-12-31	Skr1.24 Billion ≈ $133.31 Million	Skr-27.83 Million ≈ $-2.99 Million	-0.022x	-11.95%
2023-12-31	Skr1.25 Billion ≈ $134.18 Million	Skr-25.02 Million ≈ $-2.69 Million	-0.020x	+23.42%
2022-12-31	Skr1.24 Billion ≈ $133.60 Million	Skr-32.53 Million ≈ $-3.50 Million	-0.026x	-252.38%
2021-12-31	Skr971.09 Million ≈ $104.50 Million	Skr16.70 Million ≈ $1.80 Million	0.017x	+141.46%
2020-12-31	Skr800.27 Million ≈ $86.12 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.041x	-464.27%
2019-12-31	Skr1.01 Billion ≈ $108.45 Million	Skr-7.41 Million ≈ $-797.33K	-0.007x	-116.54%
2018-12-31	Skr296.01 Million ≈ $31.86 Million	Skr13.15 Million ≈ $1.42 Million	0.044x	+4.76%
2017-12-31	Skr267.12 Million ≈ $28.75 Million	Skr11.33 Million ≈ $1.22 Million	0.042x	+114.06%
2016-12-31	Skr29.82 Million ≈ $3.21 Million	Skr-8.99 Million ≈ $-967.90K	-0.302x	+76.99%
2015-12-31	Skr247.88 Million ≈ $26.68 Million	Skr-325.02 Million ≈ $-34.98 Million	-1.311x	-1890.69%
2014-12-31	Skr1.65 Billion ≈ $177.09 Million	Skr-108.39 Million ≈ $-11.66 Million	-0.066x	-50.19%
2013-12-31	Skr1.87 Billion ≈ $201.28 Million	Skr-82.03 Million ≈ $-8.83 Million	-0.044x	+41.84%
2012-12-31	Skr2.02 Billion ≈ $217.84 Million	Skr-152.65 Million ≈ $-16.43 Million	-0.075x	-22.86%
2011-12-31	Skr2.17 Billion ≈ $233.95 Million	Skr-133.44 Million ≈ $-14.36 Million	-0.061x	-8.30%
2010-12-31	Skr1.72 Billion ≈ $184.80 Million	Skr-97.32 Million ≈ $-10.47 Million	-0.057x	-231.51%
2009-12-31	Skr2.00 Billion ≈ $215.05 Million	Skr-34.16 Million ≈ $-3.68 Million	-0.017x	-56.75%
2008-12-31	Skr1.65 Billion ≈ $177.66 Million	Skr-18.00 Million ≈ $-1.94 Million	-0.011x	--

About Karolinska Development AB ser. B

ST:KDEV Sweden Biotechnology

Market Cap

$29.36 Million

Skr272.85 Million SEK

Market Cap Rank

#23797 Global

#467 in Sweden

Share Price

Skr0.29

Change (1 day)

+0.00%

52-Week Range

Skr0.25 - Skr1.04

All Time High

Skr10.82